menu search

Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023

Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that two abstracts have been accepted for poster presentations at the European Association for the Study of the Liver (EASL) Congress 2023 […] The post Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023 appeared first on... Read More
Posted: Jun 7 2023, 06:01
Author Name: forextv
Views: 102777

Search within

Pages Search Results: